Medicare Enrolled
Dr. Renjitha Ignatius, M.D.
Medical Oncology · Sun City Center, FL
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Ignatius from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Ignatius? Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Ignatius
Dr. Renjitha Ignatius is a medical oncology in Sun City Center, FL, with 18 years in practice. Based on federal Medicare data, Dr. Ignatius performed 218,759 Medicare services across 4,407 unique beneficiaries.
Between the years covered by Open Payments, Dr. Ignatius received a total of $16,864 from 99 pharmaceutical and/or device companies across 914 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in medical oncology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Ignatius is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 18 years in practice▲ Top 12% volume in FL$ $16,864 industry payments
Medicare Practice Summary
Medicare Utilization ↗218,759
Medicare services
Top 12% in FL for medical oncology
4,407
Unique beneficiaries
$9
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~12,153 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron infusion (Feraheme) | 73,950 | $0 | $4 |
| Iron sucrose injection (Venofer) | 46,200 | $0 | $5 |
| Pembrolizumab injection (Keytruda) | 22,200 | $43 | $137 |
| Anti-nausea injection (aprepitant) | 18,460 | $1 | $5 |
| Epoetin alfa injection (Procrit) for anemia | 16,080 | $6 | $23 |
| Denosumab injection (Prolia/Xgeva) | 11,820 | $18 | $51 |
| Immune globulin infusion (Gammagard) | 7,114 | $36 | $108 |
| Injection, eflapegrastim-xnst, 0.1 mg | 3,828 | $26 | $116 |
| Blood draw (venipuncture) | 2,771 | $8 | $9 |
| Complete blood count (CBC) with differential | 2,716 | $8 | $29 |
| Dexamethasone injection (steroid) | 2,262 | $0 | $3 |
| Anti-nausea injection (Aloxi/palonosetron) | 1,730 | $1 | $28 |
| Office visit, established patient (30-39 min) | 1,290 | $95 | $339 |
| Injection, fulvestrant, 25 mg | 1,120 | $8 | $132 |
| Drug injection, under skin or into muscle | 912 | $11 | $69 |
| Injection of additional new drug or substance into vein | 861 | $12 | $61 |
| Anti-nausea injection (ondansetron/Zofran) | 824 | $0 | $9 |
| Administration of chemotherapy into vein, 1 hour or less | 575 | $97 | $378 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 494 | $47 | $189 |
| Cyclophosphamide, 100 mg | 388 | $16 | $79 |
| Injection, diphenhydramine hcl, up to 50 mg | 289 | $1 | $3 |
| Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | 260 | $22 | $84 |
| Injection, methylprednisolone sodium succinate, up to 40 mg | 244 | $3 | $11 |
| Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | 239 | $1 | $6 |
| Infusion into a vein for therapy, prevention, or diagnosis, each additional hour | 191 | $15 | $56 |
| Injection, zoledronic acid, 1 mg | 183 | $7 | $69 |
| Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | 168 | $17 | $59 |
| Administration of chemotherapy into vein, each additional hour | 165 | $21 | $79 |
| Office visit, established patient, complex (40-54 min) | 161 | $133 | $474 |
| Administration of additional new drug or substance into vein, 1 hour or less | 145 | $49 | $178 |
| New patient office visit (45-59 min) | 141 | $122 | $453 |
| Office visit, established patient (20-29 min) | 139 | $66 | $239 |
| Infusion into a vein for hydration, each additional hour | 126 | $10 | $42 |
| Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | 117 | $25 | $89 |
| Injection of drug or substance into vein | 113 | $27 | $156 |
| Infusion, normal saline solution , 1000 cc | 83 | $2 | $7 |
| Automated urinalysis | 81 | $2 | $8 |
| Red blood count, automated test | 81 | $4 | $10 |
| New patient office visit, complex (60-74 min) | 71 | $166 | $585 |
| Administration of additional new drug or substance into vein using push technique | 63 | $42 | $170 |
| Infusion into a vein for hydration, 31-60 minutes | 40 | $25 | $156 |
| Drawing of blood for a medical problem | 38 | $67 | $277 |
| Initial hospital admission, moderate complexity | 13 | $103 | $377 |
| Initial hospital admission, high complexity | 13 | $127 | $556 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
37.6% high complexity
58.6% medium
3.8% routine
Industry Payment Transparency
Open Payments through 2024 ↗$16,864
Total received (2018-2024)
Avg $2,409/year across 7 years
Top 30% in FL for medical oncology
99
Companies
914
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$16,807 (99.7%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$56 (0.3%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024$4,128
2023$3,176
2022$2,209
2021$1,198
2020$1,700
2019$2,252
2018$2,201
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Novartis Pharmaceuticals Corporation
$1,241
PFIZER INC.
$1,034
E.R. Squibb & Sons, L.L.C.
$870
Lilly USA, LLC
$747
Merck Sharp & Dohme Corporation
$733
AstraZeneca Pharmaceuticals LP
$629
Amgen Inc.
$573
Janssen Biotech, Inc.
$567
GENZYME CORPORATION
$558
Incyte Corporation
$548
Celgene Corporation
$522
Merck Sharp & Dohme LLC
$485
Genentech USA, Inc.
$478
Daiichi Sankyo Inc.
$437
Astellas Pharma US Inc
$429
Eisai Inc.
$420
Gilead Sciences, Inc.
$323
Seagen Inc.
$290
Takeda Pharmaceuticals U.S.A., Inc.
$286
BeiGene USA, Inc.
$239
Alexion Pharmaceuticals, Inc.
$234
Exelixis Inc.
$228
Regeneron Healthcare Solutions, Inc.
$209
Bayer HealthCare Pharmaceuticals Inc.
$200
SOBI, INC
$185
Puma Biotechnology, Inc.
$173
GlaxoSmithKline, LLC.
$165
TESARO, Inc.
$162
Boehringer Ingelheim Pharmaceuticals, Inc.
$158
Janssen Pharmaceuticals, Inc
$149
Bayer Healthcare Pharmaceuticals Inc.
$138
ABBVIE INC.
$135
EISAI INC.
$127
TerSera Therapeutics LLC
$126
Kite Pharma, Inc.
$122
Foundation Medicine, Inc.
$121
EMD Serono, Inc.
$118
Rigel Pharmaceuticals, Inc.
$117
Karyopharm Therapeutics Inc.
$108
JAZZ PHARMACEUTICALS INC.
$106
Dendreon Pharmaceuticals LLC
$103
Sirtex Medical Inc
$101
Stemline Therapeutics Inc.
$101
Pharmacosmos Therapeutics Inc.
$93
PUMA BIOTECHNOLOGY, INC.
$87
Agios Pharmaceuticals, Inc.
$83
Seattle Genetics, Inc.
$79
TAIHO ONCOLOGY, INC.
$76
Pharmacyclics LLC, An AbbVie Company
$75
Genmab U.S., Inc.
$67
Dova Pharmaceuticals
$61
AMAG Pharmaceuticals, Inc.
$56
Kyowa Kirin, Inc.
$55
SERVIER PHARMACEUTICALS LLC
$54
Blueprint Medicines Corporation
$51
AVEO Pharmaceuticals, Inc.
$51
INSYS Therapeutics Inc
$50
Sumitomo Pharma America, Inc.
$50
Acrotech Biopharma Inc.
$49
MEDIVATION FIELD SOLUTIONS LLC
$48
Mirati Therapeutics, Inc.
$46
ARRAY BIOPHARMA INC
$40
Deciphera Pharmaceuticals Inc.
$40
Alnylam Pharmaceuticals Inc.
$38
Taiho Oncology, Inc.
$37
PharmaEssentia USA Corporation
$36
Jazz Pharmaceuticals Inc.
$35
G1 Therapeutics, Inc.
$34
CTI BioPharma Corp.
$33
Sobi, Inc
$33
SUN PHARMACEUTICAL INDUSTRIES INC.
$32
RECORDATI_RARE_DISEASES_INC.
$31
Myovant Sciences Inc.
$29
ImmunoGen, Inc.
$29
NOVARTIS PHARMACEUTICALS CORPORATION
$28
Emmaus Medical, Inc.
$28
EUSA Pharma (US) LLC
$25
MorphoSys, US Inc.
$24
SpringWorks Therapeutics, Inc.
$24
Shire North American Group Inc
$24
TOLMAR Pharmaceuticals, Inc.
$24
Boston Scientific Corporation
$23
Apellis Pharmaceuticals, Inc.
$23
ACCORD HEALTHCARE, INC.
$23
Pharmacyclics LLC, an AbbVie Company
$23
Tolmar, Inc.
$21
Partner Therapeutics, Inc.
$19
Cumberland Pharmaceuticals, Inc.
$18
Array BioPharma Inc.
$18
Helsinn Therapeutics (U.S.), Inc.
$17
Acrotech Biopharma LLC
$16
PBG PUERTO RICO LLC
$16
Legend Biotech USA Inc.
$16
ADC Therapeutics America, Inc.
$15
Servier Pharmaceuticals LLC
$14
SECURA BIO, INC.
$14
Teva Pharmaceuticals USA, Inc.
$13
Secura Bio, Inc.
$13
SANOFI-AVENTIS U.S. LLC
$12
Top 3 companies account for 18.7% of total payments
Associated products mentioned in payments ›
ABECMA · ADAKVEO · ADCETRIS · AFINITOR · ALUNBRIG · AYVAKIT · Abraxane · Alecensa · Aliqopa · Avastin · BALVERSA · BAVENCIO · BELEODAQ · BENDEKA · BESREMI · BLENREP · BOSULIF · BRAFTOVI · BRUKINSA · Bavencio · Braftovi · CABLIVI · CABOMETYX · CALQUENCE · CAMCEVI · CHANTIX · COPIKTRA · COSELA · CYRAMZA · Cabometyx · DARZALEX · DOPTELET · Doptelet · ELIGARD · ELIQUIS · ELITEK · ELREXFIO · EMPLICITI · ENHERTU · ENJAYMO · EPKINLY · ERBITUX · ERLEADA · Elahere · Empaveli · Endari · Enhertu · Epkinly · Erleada · FERAHEME · FOTIVDA · FOUNDATIONONE · FRUZAQLA · Fabhalta · GAZYVA · GILOTRIF · GIVLAARI · Halaven · IBRANCE · IMBRUVICA · IMFINZI · INJECTAFER · INLYTA · INREBIC · Imbruvica · JADENU · JAKAFI · JEVTANA · KANJINTI · KEYTRUDA · KISQALI · KRAZATI · Kadcyla · Kyprolis · LIBTAYO · LONSURF · LORBRENA · LUMAKRAS · LUTATHERA · LYNPARZA · Lenvima · Leukine · Lonsurf · MEKINIST · MONJUVI · MONOFERRIC · MVASI · MYLOTARG · NERLYNX · NINLARO · Nerlynx · Neulasta · Nexavar · Nplate · Nubeqa · OGSIVEO · OJJAARA · ONUREG · OPDIVO · OPDUALAG · ORGOVYX · OXBRYTA · Orserdu · PADCEV · PEMAZYRE · PIQRAY · PLUVICTO · PRADAXA · PROMACTA · PROVENGE · Padcev · Perjeta · Pomalyst · Poteligeo · QINLOCK · REBLOZYL · RETEVMO · RYBREVANT · RYDAPT · RYZNEUTA · Revlimid · Rezlidhia · SANCUSO · SARCLISA · SCEMBLIX · SIR-Spheres Microspheres · SOLIRIS · SPRYCEL · SUTENT · SYLVANT · SYNDROS · Soliris · Stivarga · Sylvant · TABRECTA · TAGRISSO · TASIGNA · TAXOTERE · TECENTRIQ · TIBSOVO · TIVDAK · TUKYSA · Tavalisse · Tibsovo · Trodelvy · ULTOMIRIS · Ultomiris · VENCLEXTA · VERZENIO · VONJO · Venclexta · Vitrakvi · Vonjo · Vyloy · WaveWriter Alpha Prime 16 · XALKORI · XARELTO · XGEVA · XPOVIO · XTANDI · Xofigo · Xospata · Xtandi · YONSA · Yescarta · ZEJULA · ZEPZELCA · ZOLADEX · ZYKADIA · ZYTIGA · Zoladex
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Equivalent to $8 per 100 Medicare services performed
Geographic Context
Medical Oncologys within 10 mi
59
Per 100K population
4.0
County median income
$75,011
Nearest hospital
HCA FLORIDA SOUTH SHORE HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Ignatius is a mixed practice specialist, with above-average Medicare volume (top 12% in FL), and low-engagement industry engagement, with 18 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Ignatius experienced with iron infusion (feraheme)?
Based on Medicare claims data, Dr. Ignatius performed 73,950 iron infusion (feraheme) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Ignatius receive payments from pharmaceutical companies?
Yes. Dr. Ignatius received a total of $16,864 from 99 companies across 914 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Ignatius's costs compare to other medical oncologys in Sun City Center?
Dr. Ignatius's average Medicare payment per service is $9. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Ignatius) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Medical Oncologys in Sun City Center
Browse medical oncologys in Sun City Center ranked by procedure volume and transparency data.
Highest volume
Top Medical Oncologys in FL
Medical Oncologys ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Medical Oncologys in FL
Which FL medical oncologys receive the most from drug and device companies.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
PFIZER INC. Payments to Doctors
See all physicians who received payments from PFIZER INC..
By company
E.R. Squibb & Sons, L.L.C. Payments to Doctors
See all physicians who received payments from E.R. Squibb & Sons, L.L.C..
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology